Search Results - "Al Sifri, Saud"

Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment by Al Sifri, Saud N, Almahmeed, Wael, Azar, Sami, Okkeh, Osama, Bramlage, Peter, Jünger, Claus, Halawa, Islam, Ambegaonkar, Baishali, Wajih, Sameh, Brudi, Philippe

“…Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins has been demonstrated to reduce cardiovascular risk…”
Get full text

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals by Moazin, Maher S, Baazeem, Abdulaziz, Al-Bakri, Ayman, Dayel, Adel Al, Amir, Ashraf, Sifri, Saud Al, Reda, Mona, Bashraheel, Fahad, Alfakhri, Abdullah, Hamdy, Yousef, Elshaer, Fayez

“…Erectile dysfunction (ED) is marked by a recurring incapacity to achieve or uphold a satisfactory erection during sexual activities. The study aims to increase…”
Get full text

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan by Al Sifri, Saud

“…Saud Al SifriEndocrinology Department, Alhada Armed Forces Hospital, Taif, Saudi ArabiaI read with great interest the recent review article by AlMaatouq…”
Get full text

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial by McCrimmon, Rory J., Al Sifri, Saud, Emral, Rifat, Mohan, Viswanathan, Sauque‐Reyna, Leobardo, Trescolí, Carlos, Lalic, Nebojsa, Alvarez, Agustina, Demil, Nacima, Coudert, Mathieu, Shaunik, Alka, Bonnemaire, Mireille, Rosenstock, Julio

“…Aim Premix insulin is commonly used in some regions of the world, despite the higher risk of hypoglycaemia and weight gain compared with basal insulin, based…”
Get full text

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Taif, Saudi Arabia cohort of the A 1 chieve study by El Gendy, Helmy, Al Sifri, Saud, Ghazy, Mohamed

“…Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir,…”
Get full text

The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study by Alguwaihes, Abdullah M, Alhozali, Amani, Yahia, Moataz M, Abdel-Nabi, Tarek, Hassan Hatahet, Mohamed, Albalkhi, Nader I, Al Sifri, Saud

“…To investigate cardiovascular disease (CVD) prevalence in adult patients with type 2 diabetes mellitus (T2DM) in Saudi Arabia using data from the CAPTURE…”
Get full text

A Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide Modified Release during Fasting in Gulf Cooperation Council Countries: An Analysis from the International DIA-RAMADAN Study by Hassanein, Mohamed, Al Sifri, Saud, Al Awadi, Fatheya, Alessa, Thamer, Shaaban, Ashraf

“…Abstract Introduction: The safety and effectiveness of gliclazide modified release (MR) in patients with type 2 diabetes mellitus (T2DM) who fasted during…”
Get full text

234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial by ROSENSTOCK, JULIO, EMRAL, RIFAT, SAUQUE-REYNA, LEOBARDO, MOHAN, VISWANATHAN, TRESCOLI, CARLOS, SIFRI, SAUD N. AL, LALIC, NEBOJSA, ALVAREZ, AGUSTINA, PICARD, PASCALINE, DEMIL, NACIMA, BONNEMAIRE, MIREILLE, MCCRIMMON, RORY J.

“…Introduction: iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide, offers an alternative treatment advancement option to premix…”
Get full text

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version by Hamdy, Osama, Al Sifri, Saud, Hassanein, Mohamed, Al Dawish, Mohammed, Al-Dahash, Raed A., Alawadi, Fatheya, Jarrah, Nadim, Ballout, Hajar, Hegazi, Refaat, Amin, Ahmed, Mechanick, Jeffrey I.

“…Diabetes prevalence is on the rise in the Middle East. In countries of the Gulf region—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab…”
Get full text

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with coronary heart disease in Saudi Arabia by Al Shammeri, M.D. Owayed, Sifri, Saud Al, Shammeri, Owayed, Jaser, Saleh Al

“…Hyperlipidemia is highly prevalent among patients surviving an acute coronary syndrome (ACS) and those with stable coronary heart disease (CHD). Evidence-based…”
Get full text

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe by FONSECA, VIVIAN, ROSENSTOCK, JULIO, CHENG, ALICE Y., EMRAL, RIFAT, SAUQUE-REYNA, LEOBARDO, MOHAN, VISWANATHAN, AL SIFRI, SAUD N., ALVAREZ, AGUSTINA, DJABALLAH, KHIER, PICARD, PASCALINE, SOUHAMI, ELISABETH, MCCRIMMON, RORY J.

“…Introduction: In many regions outside Europe, premix insulin is commonly used to advance therapy from BI when HbA1c targets are not met in T2D, despite a…”
Get full text

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia by Al Sifri, Saud, Al Shammeri, Owayed, Al Jaser, Saleh, Alkhenizan, Abdullah, Bin Shafi Shafiurrehman, Atif, Morcos, Bassem, Wajih, Sameh, Elnahal, Ibrahim, Horack, Martin, Brudi, Philippe, Lautsch, Dominik, Ambegaonkar, Baishali, Vyas, Ami, Baxter, Carl A, Gitt, Anselm K

“…To provide an overview of the extent of hyperlipidemia in very high-risk patients, and how lipid-lowering therapy (LLT) is used in a real-world…”
Get full text

Diagnostic accuracy of high-resolution neck ultrasonography in the follow-up of differentiated thyroid cancer: a prospective study by Alzahrani, Ali S, Alsuhaibani, Hamad, Salam, Suzan Abdel, Al Sifri, Saud N, Mohamed, Gamal, Al Sobhi, Saif, Sulaiman, Othman, Akhtar, Mohamed

“…To conduct a prospective study of the diagnostic value of features of cervical lymph nodes (large size, central location, abnormal shape, cystic changes,…”
Get more information

Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial by Rosenstock, Julio, Emral, Rifat, Sauque-Reyna, Leobardo, Mohan, Viswanathan, Trescolí, Carlos, Al Sifri, Saud, Lalic, Nebojsa, Alvarez, Agustina, Picard, Pascaline, Bonnemaire, Mireille, Demil, Nacima, McCrimmon, Rory J

“…To directly compare the efficacy and safety of a fixed-ratio combination, of insulin glargine 100 units/mL and the glucagon-like peptide 1 receptor agonist…”
Get full text

Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes by Aronson, Ronnie, Galstyan, Gagik, Goldfracht, Margalit, Al Sifri, Saud, Elliott, Lisa, Khunti, Kamlesh

“…•Insulin treatment of diabetes is compromised and more costly with hypoglycaemia.•The HAT study investigated the direct and indirect economic costs of…”
Get full text

Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence by Al Sifri, Saud, Rizvi, Kashif

“…Muslim patients with type 2 diabetes (T2D) who fast during Ramadan face challenges in diabetes management due to substantial alterations in lifestyle and…”
Get full text

Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis by Hassanein, Mohamed, Malek, Rachid, Al Sifri, Saud, Sahay, Rakesh Kumar, Buyukbese, Mehmet Akif, Djaballah, Khier, Melas-Melt, Lydie, Shaltout, Inass

“…Introduction The aim of this work was to assess the safety and effectiveness of concomitant iGlarLixi and sodium-glucose co-transporter-2 inhibitors (SGLT-2i)…”
Get full text

Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach by Mbanya, Jean Claude, Al-Sifri, Saud, Abdel-Rahim, Aly, Satman, Ilhan

“…Highlights • Individualized Ramadan-focused advice minimizes risk of hypoglycemic events (HEs). • Patients taking a DPP-4i or gliclazide when fasting during…”
Get full text

Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study by Hassanein, Mohamed, Malek, Rachid, Shaltout, Inass, Sahay, Rakesh Kumar, Buyukbese, Mehmet Akif, Djaballah, Khier, Pilorget, Valerie, Coudert, Mathieu, Al Sifri, Saud

“…To evaluate the safety and effectiveness of iGlarLixi in adults with type 2 diabetes (T2D) fasting during Ramadan. SoliRam was a multinational, prospective,…”
Get full text

Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit by Al Saleh, Yousef, Al Busaidi, Noor, Al Dahi, Waleed, Almajnoni, Munawar, Mohammed, Al Saeed, Alshali, Khalid, Al-Shamiri, Mostafa, Al Sifri, Saud, Arafah, Mohammed, Chan, Siew Pheng, El-Tamimi, Hassan, Hafidh, Khadija, Hassanein, Mohamed, Shaaban, Ashraf, Sultan, Ali, Grassi, Guido

“…Type 2 diabetes mellitus (T2DM) and hypertension are leading risk factors for death and disability in the Middle East. Both conditions are highly prevalent,…”
Get full text